Description
CJC-1295 No DAC (5mg) and Ipamorelin (5mg)
This peptide blend combines CJC-1295 No DAC (5mg) and Ipamorelin (5mg) in a convenient formulation designed exclusively for scientific research purposes. Researchers exploring peptide interactions and biochemical pathways may find this blend beneficial for their studies. Each vial is carefully synthesized and tested to ensure high purity and quality. This product is intended for laboratory research and analysis only and is not for human use. For detailed handling and storage guidelines, refer to the included specifications.
Key Details
Property |
Details |
Chemical Formula |
C203H320N56O51 |
Molecular Mass |
4359.14 g/mol |
CAS Number |
863288-34-0 &170851-70-4 |
Vial Size |
3 ml |
Vial Contents |
Lyophilized Powder |
Blend Components |
CJC-1295 No DAC 5mg, Ipamorelin 5mg |
Details
Intended Use: This peptide blend of CJC-1295 No DAC and Ipamorelin is designed for
research purposes only and comes in lyophilized form and must be reconstituted.
Storage: Store the vial in a cool, dry place away from direct sunlight. Once reconstituted, keep refrigerated at 2-8°C.
Solubility: Reconstitute with bacteriostatic water for optimal results.
Shelf Life: The lyophilized form has a shelf life of 24 months when stored properly. After reconstitution, refrigerate and use within 4-6 weeks.
Handling: Maintain sterile techniques to preserve the product’s integrity during research applications.
Research
Research Section: Studies on CJC-1295 No DAC and Ipamorelin Blend
Research into the combined use of CJC-1295 No DAC and Ipamorelin has explored their potential synergistic effects on growth hormone (GH) secretion. While direct studies on this specific combination are limited, findings from individual research on each peptide provide valuable insights into their potential combined outcomes.
CJC-1295 No DAC Research
- Growth Hormone Release:
Studies have demonstrated that CJC-1295 can significantly enhance GH levels. For example, a single administration of CJC-1295 in animal models resulted in elevated GH levels lasting up to six days.
- Insulin-Like Growth Factor 1 (IGF-1) Levels:
Research indicates that CJC-1295 administration leads to a sustained increase in IGF-1 levels, with reports of a 44% increase following a single injection.
Ipamorelin Research
- Growth Hormone Secretion:
Ipamorelin has been observed to stimulate GH release in a pulsatile manner, producing short-term GH spikes. It selectively targets GH pathways, minimizing effects on other hormones.
- Bone Growth:
Research suggests that Ipamorelin promotes bone growth by stimulating both mineralization of existing bone and deposition of new bone tissue.
Combined Use of CJC-1295 No DAC and Ipamorelin
Mechanism of Action
The CJC-1295 No DAC and Ipamorelin blend operates through complementary mechanisms that amplify growth hormone (GH) secretion by targeting different points in the GH regulatory pathway. Their combined action enhances research opportunities to study GH dynamics in various contexts.
CJC-1295 No DAC: Mechanism of Action
CJC-1295 No DAC is a growth hormone-releasing hormone (GHRH) analog, designed to mimic the action of naturally occurring GHRH. It works by binding to the GHRH receptors located on the anterior pituitary gland.
- Stimulation of GH Release:
- IGF-1 Stimulation:
- Prolonged Activity Without DAC:
Ipamorelin: Mechanism of Action
Ipamorelin is a selective growth hormone secretagogue (GHS) and a ghrelin receptor agonist. It acts differently from GHRH analogs, targeting receptors that mimic the action of the hormone ghrelin.
- Stimulation of GH Secretion:
- Endogenous Ghrelin Mimicry:
Synergistic Mechanism of the Blend
When used together, CJC-1295 No DAC and Ipamorelin create a synergistic effect on GH secretion due to their complementary actions:
- CJC-1295 No DAC: Provides sustained baseline elevation of GH levels by stimulating the pituitary over an extended period.
- Ipamorelin: Enhances short-term GH spikes, complementing CJC-1295’s prolonged activity to create a more dynamic GH profile.
The result is a consistent baseline of elevated GH levels with intermittent spikes, closely mimicking natural GH secretion patterns in vivo. This synergy makes the blend a valuable tool for researchers studying:
- GH-IGF-1 axis interactions.
- Physiological effects of sustained GH elevation.
- GH’s role in metabolism, tissue repair, and growth.
Note: This description is intended for research and educational purposes only and does not imply or suggest human use.